SCGY · As filed with the SEC
Scientific Energy cash flow statement, by quarter
The statement as Scientific Energy presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Unaudited Condensed Consolidated Statements of Cash Flows · USD
| USD | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Profit or Loss | 345,293† | 73,165† | 143,535 | — |
| Adjustments to reconcile net income to net cash provided by operating activities | ||||
| Depreciation Expense | 23,296† | 19,709† | 22,020 | 17,626† |
| Goodwill Impairment | 40,986† | 39,918† | 39,468 | 40,051† |
| Loss on disposal of property and equipment | 22† | (26)† | 2,813 | — |
| Loss of disposal of a subsidiary | 0† | 0† | 0 | — |
| Impairment loss on loan receivables | 12,292† | 131,857† | 102,906 | — |
| Change in operating assets and liabilities | ||||
| Account receivables | (109,840)† | (3,792,255)† | (811,934) | — |
| Other receivables | (47,066)† | (93,870)† | 2,779 | — |
| Inventories | (52,032)† | 79,769† | (119,133) | — |
| Deposits | (7,629)† | 26,071† | (2,545) | — |
| Prepaid expenses | (3,026,367)† | 1,208,400† | 2,315,191 | — |
| Accounts payable | (1,152,081)† | 1,065,912† | (3,669,799) | — |
| Accrued expenses | 109,868† | (438,190)† | 274,507 | — |
| Net Cash from Financing Activities | 676,559† | (57,460)† | 862,888 | — |
| Other payables | 2,725,500† | 2,871,292† | 2,328,286 | — |
| Net cash provided by operating activities | (462,706)† | 1,134,292† | 1,490,982 | — |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Purchase of property, plant and equipment | (96,017)† | (3,899)† | (32,966) | — |
| Repayment from related companies | 51,068† | (48,372)† | 66,805 | — |
| Repayment from shareholder | — | — | 0 | — |
| Repayment from associate | — | — | 0 | — |
| Net cash outflow from disposal of subsidiary | 0† | — | — | — |
| Loan to joint venture | (12,292)† | (131,857)† | (102,906) | — |
| Net cash used in investing activities | (168,980)† | (184,128)† | (69,067) | — |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Repayment of bank loans | (3,347,374)† | (1,741,002)† | (1,706,332) | — |
| Drawdown of bank loans | 3,291,991† | 1,603,741† | 1,066,551 | — |
| Net cash (used in) / provided by financing activities | (55,383)† | (137,261)† | (639,781) | — |
| Effect of Exchange Rate on Cash | (27,995)† | 2,551† | (1,422) | — |
| Net increase in cash and cash equivalents | (715,064)† | 815,454† | 780,712 | — |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance | 6,510,725 | 5,695,271 | 4,914,559 | 6,795,889 |
| Reported | — | — | — | 4,914,559 |
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance | 5,795,661 | 6,510,725 | 5,695,271 | — |
| Reported | — | — | — | 4,914,559 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||||
| Interest Expense | 991† | 4,238† | 7,132 | — |
| Income Tax Expense | 5,181† | 0† | 0 | — |
| Record right-of-use assets upon adoption of ASC 842 | (287,975)† | (729,687)† | 1,017,662 | — |
| Record lease liabilities upon adoption of ASC 842 | (287,975)† | (729,687)† | 1,017,662 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.